2021
DOI: 10.1111/1440-1681.13595
|View full text |Cite
|
Sign up to set email alerts
|

Propofol suppresses cell proliferation in gastric cancer cells through NRF2‐mediated polyol pathway

Abstract: Propofol, a short-acting intravenous sedative agent, is often used in clinical practice for intraoperative general anaesthesia and postoperative sedation. 1,2 A growing body of evidence has demonstrated that propofol has a novel function in tumour cell proliferation, invasion, migration, and apoptosis in lung cancer, 3 gastrointestinal tract, [4][5][6] breast cancer, 7 ovarian 5 and cervical cancer. 8 Furthermore, studies have confirmed that propofol induced a metabolic switch to glycolysis and cell death, 9 a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 57 publications
0
2
0
1
Order By: Relevance
“…However, numerous studies have produced the opposite findings for different cancers. More recently, this dysfunction of metabolic reprogramming was documented on gastric cancer cells; however, in this case, the cell proliferation was suppressed through the Nrf2-mediated polyol pathway [39].…”
Section: Effect On Cancer Treatmentmentioning
confidence: 91%
“…However, numerous studies have produced the opposite findings for different cancers. More recently, this dysfunction of metabolic reprogramming was documented on gastric cancer cells; however, in this case, the cell proliferation was suppressed through the Nrf2-mediated polyol pathway [39].…”
Section: Effect On Cancer Treatmentmentioning
confidence: 91%
“…Так, Yajun Cao із співавт. показали, що пропофол пригнічує проліферацію клітин, що може визначити його вибір для седації пацієнтів із раком шлунка [14]. До того ж пропофол може інгібувати інвазію, міграцію, проліферацію епітеліально-мезентеріальних клітин у печінковоклітинній карциномі, сприяючи експресії miР-363 [15], а також пригнічувати проліферацію, міграцію клітин остеосаркоми через вісь FOXO1/TUSC7, регулюючи передачу сигналів AKT/GSK3β [16].…”
Section: особливості реакцій організму дітей з онкологічними захворюв...unclassified
“…13,14 Complete surgical resection is still the only way to cure gastric cancer, so it is vital to identify the factors that influence the long-term prognosis of patients with gastric cancer after radical surgery during anaesthesia in order to improve the prognosis. Propofol, a widely used short-acting intravenous sedative drug, is gradually gaining attention due to its tumorsuppressive and non-anaesthetic effects, 15 which can reduce the migration and invasion of gastric cancer MGC-803 cells by inhibiting HDAC1 expression and the downstream p38MAPK pathway, 16 and also inhibit gastric cancer cell proliferation and migration by upregulating microRNA-29 cell proliferation and migration through upregulation of microRNA-29. 17 Relevant clinical studies have shown that propofol can inhibit tumor growth and metastatic activity.…”
mentioning
confidence: 99%